Betta Pharmaceuticals (China) Probability of Future Stock Price Finishing Over 49.36

300558 Stock   49.36  3.74  7.04%   
Betta Pharmaceuticals' future price is the expected price of Betta Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Betta Pharmaceuticals Co performance during a given time horizon utilizing its historical volatility. Check out Betta Pharmaceuticals Backtesting, Betta Pharmaceuticals Valuation, Betta Pharmaceuticals Correlation, Betta Pharmaceuticals Hype Analysis, Betta Pharmaceuticals Volatility, Betta Pharmaceuticals History as well as Betta Pharmaceuticals Performance.
  
Please specify Betta Pharmaceuticals' target price for which you would like Betta Pharmaceuticals odds to be computed.

Betta Pharmaceuticals Target Price Odds to finish over 49.36

The tendency of Betta Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 49.36 90 days 49.36 
about 11.41
Based on a normal probability distribution, the odds of Betta Pharmaceuticals to move above the current price in 90 days from now is about 11.41 (This Betta Pharmaceuticals Co probability density function shows the probability of Betta Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Betta Pharmaceuticals has a beta of 0.0446. This suggests as returns on the market go up, Betta Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Betta Pharmaceuticals Co will be expected to be much smaller as well. Additionally Betta Pharmaceuticals Co has an alpha of 0.6101, implying that it can generate a 0.61 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Betta Pharmaceuticals Price Density   
       Price  

Predictive Modules for Betta Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Betta Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
43.3247.9152.50
Details
Intrinsic
Valuation
LowRealHigh
41.4145.9950.58
Details
Naive
Forecast
LowNextHigh
46.7551.3455.94
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.250.250.25
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Betta Pharmaceuticals. Your research has to be compared to or analyzed against Betta Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Betta Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Betta Pharmaceuticals.

Betta Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Betta Pharmaceuticals is not an exception. The market had few large corrections towards the Betta Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Betta Pharmaceuticals Co, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Betta Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.61
β
Beta against Dow Jones0.04
σ
Overall volatility
6.05
Ir
Information ratio 0.11

Betta Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Betta Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Betta Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Betta Pharmaceuticals appears to be risky and price may revert if volatility continues
About 48.0% of the company shares are owned by insiders or employees
Latest headline from news.google.com: Betta Pharmaceuticals Third Quarter 2024 Earnings Beats Expectations - Simply Wall St

Betta Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Betta Stock often depends not only on the future outlook of the current and potential Betta Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Betta Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding418.5 M

Betta Pharmaceuticals Technical Analysis

Betta Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Betta Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Betta Pharmaceuticals Co. In general, you should focus on analyzing Betta Stock price patterns and their correlations with different microeconomic environments and drivers.

Betta Pharmaceuticals Predictive Forecast Models

Betta Pharmaceuticals' time-series forecasting models is one of many Betta Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Betta Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Betta Pharmaceuticals

Checking the ongoing alerts about Betta Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Betta Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Betta Pharmaceuticals appears to be risky and price may revert if volatility continues
About 48.0% of the company shares are owned by insiders or employees
Latest headline from news.google.com: Betta Pharmaceuticals Third Quarter 2024 Earnings Beats Expectations - Simply Wall St

Other Information on Investing in Betta Stock

Betta Pharmaceuticals financial ratios help investors to determine whether Betta Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Betta with respect to the benefits of owning Betta Pharmaceuticals security.